Click on a filter below to refine your search. Remove a filter to broaden your search.
The incidence of death or postacute sequelae of SARS-CoV-2 was slightly lower with prevalent metformin use.
A reduced risk for Alzheimer’s disease, vascular dementia and Parkinson’s disease was seen with SGLT2i use in type 2 diabetes.